Pei Yu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Pei Yu has a total of 53 co-authors. Here are the top co-authors by number of shared publications:
Yuqiang Wang
Institute of New Drug Research, College of Pharmacy, Jinan University, Guangzhou 510632, China
4 shared publications- Baojian Wu
Institute of Molecular Rhythm and Metabolism, Guangzhou University of Chinese Medicine, Guangzhou 510006, China
3 shared publications Lu Gao
College of Pharmacy, Jinan University, 601 Huangpu Avenue West, Guangzhou, China
2 shared publicationsMing Lang
Jinan University College of Pharmacy
2 shared publicationsShuai Wang
College of Pharmacy, Jinan University, 601 Huangpu Avenue West, Guangzhou, China
2 shared publications- Xiaojian Jiang
State Key Laboratory of Bioactive Molecules and Druggability Assessment, Jinan University, Guangzhou 510632, China
2 shared publications
Latest Publications
- 25 June 2022
- Published by Royal Society of Chemistry (RSC) in Organic Chemistry Frontiers
- Vol. 9 (16) , 4372-4378
Accessing chiral 2,2-disubstituted morpholines via organocatalytic enantioselective chlorocycloetherification
A catalytic asymmetric halocycloetherification process is developed to achieve enantioenriched quaternary 2,2-disubstituted morpholines using an organo-catalyst.
- 25 June 2022
- Published by Royal Society of Chemistry (RSC) in Organic Chemistry Frontiers
- Vol. 9 (16) , 4372-4378
Accessing chiral 2,2-disubstituted morpholines via organocatalytic enantioselective chlorocycloetherification
A catalytic asymmetric halocycloetherification process is developed to achieve enantioenriched quaternary 2,2-disubstituted morpholines using an organo-catalyst.
- 1 August 2019
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 308, 288-293
Circadian Cyp3a11 metabolism contributes to chronotoxicity of hypaconitine in mice
- 1 August 2019
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 308, 288-293
Circadian Cyp3a11 metabolism contributes to chronotoxicity of hypaconitine in mice
- Open Access
- 1 August 2019
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 116, 108973
Bilirubin alleviates alum–induced peritonitis through inactivation of NLRP3 inflammasome
- 1 August 2019
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 116, 108973
Open AccessBilirubin alleviates alum–induced peritonitis through inactivation of NLRP3 inflammasome
- 1 May 2019
- Published by Elsevier in Biochemical Pharmacology
- Vol. 163, 215-224
The transcription factor E4bp4 regulates the expression and activity of Cyp3a11 in mice
- 1 May 2019
- Published by Elsevier in Biochemical Pharmacology
- Vol. 163, 215-224
The transcription factor E4bp4 regulates the expression and activity of Cyp3a11 in mice
- Open Access
- 17 October 2018
- Published by Georg Thieme Verlag KG in SynOpen
- Vol. 02 (04) , 0293-0297
Enantioselective Bromolactonization of Deactivated Olefinic Acids: Studies Toward the Synthesis of Brominated Isochroman-1,4-diones
† These authors contributed equally to this work. Enantioselective bromolactonization using an amino-carbamate catalyst to generate brominated isochroman-1,4-diones is described. Excellent yields and moderate enantioselectivities were achieved.
- 17 October 2018
- Published by Georg Thieme Verlag KG in SynOpen
- Vol. 02 (04) , 0293-0297
Open AccessEnantioselective Bromolactonization of Deactivated Olefinic Acids: Studies Toward the Synthesis of Brominated Isochroman-1,4-diones
† These authors contributed equally to this work. Enantioselective bromolactonization using an amino-carbamate catalyst to generate brominated isochroman-1,4-diones is described. Excellent yields and moderate enantioselectivities were achieved.
- Open Access
- 21 January 2015
- Published by Oxford University Press (OUP) in Journal of Chromatographic Science
- Vol. 53 (6) , 872-878
Pharmacokinetic and Metabolic Studies of ADTM: A Novel Danshensu Derivative Confers Cardioprotection by HPLC-UV and LC-MS/MS
(R)-(3,5,6-Trimethylpyrazinyl) methyl-2-acetoxy-3-(3,4-diacetoxyphenyl) propanoate (ADTM) is a novel Danshensu (DSS) derivative regarded as a potential new agent for the treatment of myocardial ischemia. A validated high performance liquid chromatography (HPLC) approach with a detection limit of 5 ng/mL was used for pharmacokinetic evaluation of ADTM in rat plasma. The intra- and interday precision in terms of relative standard deviation were t1/2 was 34.33 ± 11.51 and 29.94 ± 8.19 min after oral and intravenous administration of 20 mg/kg. In addition, the major metabolites both in vitro and in vivo were 2-hydroxymethy-3,5,6-trimethylpyrazin and DSS. The results indicated that the hydrolysis was the main metabolic pathway of ADTM, and carboxylesterase may play an important role in ADTM's metabolism. The present work provides basic information for ADTM's further preclinical research and DSS's chemical structure modification.
- 21 January 2015
- Published by Oxford University Press (OUP) in Journal of Chromatographic Science
- Vol. 53 (6) , 872-878
Open AccessPharmacokinetic and Metabolic Studies of ADTM: A Novel Danshensu Derivative Confers Cardioprotection by HPLC-UV and LC-MS/MS
(R)-(3,5,6-Trimethylpyrazinyl) methyl-2-acetoxy-3-(3,4-diacetoxyphenyl) propanoate (ADTM) is a novel Danshensu (DSS) derivative regarded as a potential new agent for the treatment of myocardial ischemia. A validated high performance liquid chromatography (HPLC) approach with a detection limit of 5 ng/mL was used for pharmacokinetic evaluation of ADTM in rat plasma. The intra- and interday precision in terms of relative standard deviation were t1/2 was 34.33 ± 11.51 and 29.94 ± 8.19 min after oral and intravenous administration of 20 mg/kg. In addition, the major metabolites both in vitro and in vivo were 2-hydroxymethy-3,5,6-trimethylpyrazin and DSS. The results indicated that the hydrolysis was the main metabolic pathway of ADTM, and carboxylesterase may play an important role in ADTM's metabolism. The present work provides basic information for ADTM's further preclinical research and DSS's chemical structure modification.
- 1 January 2015
- Published by Asian Publication Corporation in Asian Journal of Chemistry
- Vol. 27 (7) , 2545-2547
Synthesis of 3-(5H-Pyrazolyl)cyclobutanone Derivatives
- 1 January 2015
- Published by Asian Publication Corporation in Asian Journal of Chemistry
- Vol. 27 (7) , 2545-2547
Synthesis of 3-(5H-Pyrazolyl)cyclobutanone Derivatives
- 22 December 2014
- Published by Royal Society of Chemistry (RSC) in MedChemComm
- Vol. 6 (4) , 586-591
Synthesis and relationship of stability and biological activity of new DSS and TMP conjugates
A series of novel conjugates of danshensu (DSS) and tetramethylpyrazine (TMP) were designed and synthesized. Their stability toward hydrolysis by carboxylesterase and cardioprotective effect against t-BHP- and doxorubicin-induced damage were evaluated in H9c2 cells. The results revealed that increasing steric hindrance with bulky groups at the linkage position between DSS and TMP prolonged the half-life and also markedly increased the protective effect. Compound 7 was the most potent in protecting against t-BHP- and doxorubicin-induced damage. The protective effect of compound 7 may in part be attributed to its promotion of mitochondrial biogenesis.
- 22 December 2014
- Published by Royal Society of Chemistry (RSC) in MedChemComm
- Vol. 6 (4) , 586-591
Synthesis and relationship of stability and biological activity of new DSS and TMP conjugates
A series of novel conjugates of danshensu (DSS) and tetramethylpyrazine (TMP) were designed and synthesized. Their stability toward hydrolysis by carboxylesterase and cardioprotective effect against t-BHP- and doxorubicin-induced damage were evaluated in H9c2 cells. The results revealed that increasing steric hindrance with bulky groups at the linkage position between DSS and TMP prolonged the half-life and also markedly increased the protective effect. Compound 7 was the most potent in protecting against t-BHP- and doxorubicin-induced damage. The protective effect of compound 7 may in part be attributed to its promotion of mitochondrial biogenesis.
- 1 June 2014
- Published by Elsevier in International Immunopharmacology
- Vol. 20 (2) , 377-382
Protective effects of apocynin nitrone on acute lung injury induced by lipopolysaccharide in rats
- 1 June 2014
- Published by Elsevier in International Immunopharmacology
- Vol. 20 (2) , 377-382
Protective effects of apocynin nitrone on acute lung injury induced by lipopolysaccharide in rats